|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL.: (2006.01) |
G01N 33/66 A61K 38/43 C07K 5/00 C12M 1/34 C12M 1/40 C12N 9/14 C12N 9/18 C12N 9/36 C12N 9/52 C12N 9/66 C12N 9/78 C12N 11/00 C12P 21/02 C12P 21/06 C12Q 1/00 C12Q 1/37 G01N 33/531 |
| (11) | Number of the document | 3366 |
| (13) | Kind of document | B |
| (21) | Application number | IP1077 |
| (22) | Date of filing the application | 1993-09-22 |
| (41) | Date of publication of the application | 1995-04-25 |
| (45) | Date of publication of patent | 1995-07-25 |
| (30) | Number | Date | Country code |
| 562280 | 1990-08-03 | US | |
| PCT/US91/05415 | 1991-07-30 | WO |
| (71) |
VERTEX PHARMACEUTICALS INCORPORATED,
40 Allston Street, Cambridge, MA 02139-4211,
US
|
| (72) |
Manuel A. NAVIA, US
Nancy L. ST.CLAIR, US |
| (73) |
VERTEX PHARMACEUTICALS INCORPORATED,
40 Allston Street, Cambridge, MA 02139-4211,
US
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | CROSSLINKED CRYSTALS AS A NOVEL FORM OF ENZYME IMMOBILIZATION |
| Payment date | Validity (years) | Amount | |
| 2009-09-01 | 17 | 1200.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2010-09-22 |